Answers are grounded in this paper and cite their sources.
Simulation study assesses vancomycin exposure in preterm neonates, suggesting model choice impacts dosing decisions.
Model selection affects simulated vancomycin AUC24 values and PTA in neonates, influencing dosing decisions. These findings highlight model characteristics correlating with target attainment.
No takes yet. Share an insight, caveat, or question.
Hassani et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: